392 related articles for article (PubMed ID: 9649155)
41. Predicting patients at risk for pain associated with electrochemotherapy.
Quaglino P; Matthiessen LW; Curatolo P; Muir T; Bertino G; Kunte C; Odili J; Rotunno R; Humphreys AC; Letulé V; Marenco F; Cuthbert C; Albret R; Benazzo M; De Terlizzi F; Gehl J
Acta Oncol; 2015 Mar; 54(3):298-306. PubMed ID: 25591818
[TBL] [Abstract][Full Text] [Related]
42. Electrochemotherapy of cutaneous metastases in malignant melanoma.
Rols MP; Bachaud JM; Giraud P; Chevreau C; Roché H; Teissié J
Melanoma Res; 2000 Oct; 10(5):468-74. PubMed ID: 11095408
[TBL] [Abstract][Full Text] [Related]
43. Utility of electrochemotherapy in melanoma treatment.
Testori A; Rossi CR; Tosti G
Curr Opin Oncol; 2012 Mar; 24(2):155-61. PubMed ID: 22249204
[TBL] [Abstract][Full Text] [Related]
44. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach.
Testori A; Tosti G; Martinoli C; Spadola G; Cataldo F; Verrecchia F; Baldini F; Mosconi M; Soteldo J; Tedeschi I; Passoni C; Pari C; Di Pietro A; Ferrucci PF
Dermatol Ther; 2010; 23(6):651-61. PubMed ID: 21054709
[TBL] [Abstract][Full Text] [Related]
45. Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area.
Landström F; Kristiansson S; Appelros P
Anticancer Res; 2021 Jul; 41(7):3519-3522. PubMed ID: 34230147
[TBL] [Abstract][Full Text] [Related]
46. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.
Campana LG; Mocellin S; Basso M; Puccetti O; De Salvo GL; Chiarion-Sileni V; Vecchiato A; Corti L; Rossi CR; Nitti D
Ann Surg Oncol; 2009 Jan; 16(1):191-9. PubMed ID: 18987914
[TBL] [Abstract][Full Text] [Related]
47. Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).
Clover AJP; de Terlizzi F; Bertino G; Curatolo P; Odili J; Campana LG; Kunte C; Muir T; Brizio M; Sersa G; Pritchard Jones R; Moir G; Orlando A; Banerjee SM; Kis E; McCaul JA; Grischke EM; Matteucci P; Mowatt D; Bechara FG; Mascherini M; Lico V; Giorgione R; Seccia V; Schepler H; Pecorari G; MacKenzie Ross AD; Bisase B; Gehl J
Eur J Cancer; 2020 Oct; 138():30-40. PubMed ID: 32836172
[TBL] [Abstract][Full Text] [Related]
48. Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis.
Seyed Jafari SM; Jabbary Lak F; Gazdhar A; Shafighi M; Borradori L; Hunger RE
Eur J Dermatol; 2018 Jun; 28(3):287-313. PubMed ID: 30105989
[TBL] [Abstract][Full Text] [Related]
49. Electrochemotherapy: aspects of preclinical development and early clinical experience.
Larkin JO; Collins CG; Aarons S; Tangney M; Whelan M; O'Reily S; Breathnach O; Soden DM; O'Sullivan GC
Ann Surg; 2007 Mar; 245(3):469-79. PubMed ID: 17435555
[TBL] [Abstract][Full Text] [Related]
50. How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients.
Tijink BM; De Bree R; Van Dongen GA; Leemans CR
Clin Otolaryngol; 2006 Oct; 31(5):447-51. PubMed ID: 17014460
[TBL] [Abstract][Full Text] [Related]
51. Electrochemotherapy and its controversial results in patients with head and neck cancer.
Seccia V; Muscatello L; Dallan I; Bajraktari A; Briganti T; Ursino S; Galli L; Falcone A; Sellari-Franceschini S
Anticancer Res; 2014 Feb; 34(2):967-72. PubMed ID: 24511041
[TBL] [Abstract][Full Text] [Related]
52. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.
Caracò C; Mozzillo N; Marone U; Simeone E; Benedetto L; Di Monta G; Di Cecilia ML; Botti G; Ascierto PA
BMC Cancer; 2013 Dec; 13():564. PubMed ID: 24289268
[TBL] [Abstract][Full Text] [Related]
53. Treatment of cutaneous nodules using electrochemotherapy.
Heller R
J Fla Med Assoc; 1995 Feb; 82(2):147-50. PubMed ID: 7535837
[TBL] [Abstract][Full Text] [Related]
54. Electrochemotherapy in cancer patients: first clinical trial in Greece.
Skarlatos I; Kyrgias G; Mosa E; Provatopoulou X; Spyrou M; Theodorou K; Lepouras A; Gounaris A; Koukourakis M
In Vivo; 2011; 25(2):265-74. PubMed ID: 21471545
[TBL] [Abstract][Full Text] [Related]
55. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.
Solari N; Spagnolo F; Ponte E; Quaglia A; Lillini R; Battista M; Queirolo P; Cafiero F
J Surg Oncol; 2014 Mar; 109(3):270-4. PubMed ID: 24165992
[TBL] [Abstract][Full Text] [Related]
56. Long term effectiveness of electrochemotherapy for the treatment of lower lip squamous cell carcinoma.
Gargiulo M; Serra Mestre JM; Cortese A; Murphy DC; Parascandolo S; Razzano S
J Craniomaxillofac Surg; 2018 Nov; 46(11):1968-1974. PubMed ID: 30244963
[TBL] [Abstract][Full Text] [Related]
57. [Electrochemotherapy, a new antitumor treatment: first clinical trial].
Mir LM; Belehradek M; Domenge C; Orlowski S; Poddevin B; Belehradek J; Schwaab G; Luboinski B; Paoletti C
C R Acad Sci III; 1991; 313(13):613-8. PubMed ID: 1723647
[TBL] [Abstract][Full Text] [Related]
58. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas.
Kis EG; Baltás E; Ócsai H; Vass A; Németh IB; Varga E; Oláh J; Kemény L; Tóth-Molnár E
Sci Rep; 2019 Mar; 9(1):4285. PubMed ID: 30862897
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of electrochemotherapy in ulcerated basal cell carcinoma.
Richetta AG; Curatolo P; D'Epiro S; Mancini M; Mattozzi C; Giancristoforo S; Rotunno R; Calvieri S
Clin Ter; 2011; 162(5):443-5. PubMed ID: 22041802
[TBL] [Abstract][Full Text] [Related]
60. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver.
Engström PE; Ivarsson K; Tranberg KG; Stenram U; Salford LG; Persson BR
Anticancer Res; 2001; 21(3B):1817-22. PubMed ID: 11497264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
